This review discusses the prevalence, mechanisms, and management of atrial fibrillation, particularly lone AF, in athletes.
AF in athletes merits clinical vigilance; leaves open prospective trials for evidence-based lone AF management.
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in clinical practice with an estimated prevalence of 0.4% to 1% in the general population [1], increasing with age to 8% in those older than 80 years The recognised risk factors for developing AF include age, structural heart disease, hypertension, diabetes mellitus and hyperthyroidism However, the mechanisms underlying the onset and maintenance of AF in patients younger than 60 years in whom no cardiovascular disease or any other known causal factor is present are yet to be clarified. This condition is termed lone AF [4], and may be responsible for as many as 30% of patients with paroxysmal AF seeking medical attention
No takes yet. Share an insight, caveat, or question.
A 2011 study studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: